Search - tctmd.com

Displaying 1 - 20 of 95

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1417: Valve-Through-Valve Bailout: Successful Sapien TAVR via Dislodged CoreValve Snared in Ascending Aorta

Presenter: Ghulam Mujtaba Ghumman

October 27, 2025

Presentation TCT 2025

TCT 726: Coronary Obstruction Following Transcatheter Aortic Valve Replacement Using CoreValve or Evolut in Native Aortic Stenosis: A Systematic Review

Presenter: Aoi Omori

October 25, 2025

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

TCT 1469: No Time to Spare: Post TAVR AI and Hemodynamic Instability After CoreValve Deployment Treated With Valve-in-Valve Placement of Sapien Device

Presenter: Muhammad Sabih Saleem

October 29, 2024

Presentation TCT 2023

TCT 133: Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis

Presenter: Kendra Grubb

October 24, 2023

Presentation TCT 2022

TCT 674: Implantation of TAVR with Corevalve in patient with lipodystrophy and severe aortic regurgitation.

Presenter: Prasanthi Yelavarthy

September 17, 2022

Presentation TCT 2022

TCT 770: S3 Ultra can be used to anchor the CoreValve in ventricular migration during transcatheter aortic valve replacement in pure aortic insufficiency

Presenter: Sanskriti Shrivastava

September 17, 2022

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Michael O'Riordan

October 16, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

Presentation TCT 2018

TCT-13: 5-Year Outcomes From the Randomized Corevalve USPivotal High Risk Trial: Final Results

Presenter: Charles J. Davidson, Jeffrey J. Popma, Thomas Gleason

September 21, 2018

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

Presentation TCT 2016

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Presenter: Neil E. Moat, John G. Webb, Pieter R. Stella

October 31, 2016

Presentation TCT 2016

TCT 1515: The Dance of the Corevalve

Presenter: Jean-Claude Laborde, Thomas Walther, Smriti Saraf

October 31, 2016

Presentation TCT 2016

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Presenter: Charles J. Davidson, Michael J. Reardon, James B. Hermiller Jr.

October 31, 2016

Advertisement

TCT 1417: Valve-Through-Valve Bailout: Successful Sapien TAVR via Dislodged CoreValve Snared in Ascending Aorta

TCT 726: Coronary Obstruction Following Transcatheter Aortic Valve Replacement Using CoreValve or Evolut in Native Aortic Stenosis: A Systematic Review

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

TCT 1469: No Time to Spare: Post TAVR AI and Hemodynamic Instability After CoreValve Deployment Treated With Valve-in-Valve Placement of Sapien Device

TCT 133: Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis

TCT 674: Implantation of TAVR with Corevalve in patient with lipodystrophy and severe aortic regurgitation.

TCT 770: S3 Ultra can be used to anchor the CoreValve in ventricular migration during transcatheter aortic valve replacement in pure aortic insufficiency

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Portico Noninferior to Commercial TAVR Valves in IDE Study

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

TCT-13: 5-Year Outcomes From the Randomized Corevalve USPivotal High Risk Trial: Final Results

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

TCT 1515: The Dance of the Corevalve

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content